OTIS Autoimmune Diseases in Pregnancy Study OTIS Annual Research Meeting June 2010
Background Project began in 2000 with one sponsor, Sanofi-Aventis, to prospectively follow women exposed to leflunomide for the treatment of rheumatoid arthritis The Project is currently funded by eight pharmaceutical companies Prospective, observational cohort study Coordinating center is at the University of California, San Diego
Purpose The purpose of the research study is to evaluate the risks to the developing fetus from autoimmune diseases and the safety of medications used to treat these diseases during pregnancy.
Study Participation • Self-enrollment • 3-4 phone interviews (intake, 20wk, 32wk, outcome) • Medical records pertaining to the pregnancy and outcome of the pregnancy • Free non-invasive pediatric exam
Marketing Plans 2010 • Scientific Meetings: • 16 trade shows • Quarterly Mailings and Email Updates • Journal Advertisements • Internet Advertisements
How to Refer? • Toll-free number at 877-311-8972 to refer patient OR provide the patient our toll-free number • Contact via email at firstname.lastname@example.org • Fax a referral sheet to OTIS which is found on our website at www.otispregnancy.org